Scorecard
| Current Price | Fair | |
| Yield (%) – Higher is better Current Yield: 4.04% Industry Average: 2.96% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 3.33% Industry Average: 6.39% | ||
| Returns (%) – Higher is better Returns: 2.21% Industry Average: 18.66% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 39.95% Industry Average: 50.16% | ||
BRISTOL-MYERS SQUIBB COMPANY
(XNYS:BMY)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 62.34 | $ -0.03 |
Dividend
|
Annual Dividend
|
Annual Yield
|
|
$ 2.52
|
4.04 %
|
|
Dividend Streak
|
5 Year Average
|
|
17 year(s)
|
3.93 %
|
Fair Price
Current Stock price is considered: Fair
| Current Price ● $ 62.34 |
| Less Than $51.99 | $51.99 – $82.13 | More Than $82.13 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
|
1 Year
|
3 Year
|
5 Year
|
|
3.33 %
|
4.72 %
|
6.65 %
|
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 1.96 | $ 2.16 | $ 2.28 | $ 2.40 | $ 2.48 |
Price Return
|
1 Year
|
5 Year
|
CAGR 5 Years
|
|
$ 1.35
2.21 % |
$ -0.79
|
-0.25 %
|